Duisburg, 13 January 2014. Franz Haniel & Cie. GmbH (Haniel) regrets that the public takeover bid for Celesio AG by the US healthcare services company McKesson Corporation (McKesson) was not successful, and therefore the sale of Haniel's 50.01% interest in Celesio will not materialise.
The deadline for all bearers of Celesio shares and convertible bonds to tender their securities for €23.50 ended at midnight last Thursday. Following the count, it has been found today that McKesson did not achieve tight its intended majority of more than 75% of the total capital of Celesio AG. Its voluntary public bid is therefore invalid.
Stephan Gemkow, CEO of Haniel, said: "McKesson would have been a very good partner for the ongoing strategic development of Celesio. Thus, it is a pity that the takeover bid has failed. Nonetheless, it is not the end of the world for either Haniel or Celesio AG, which is strategically very well positioned. We can now take our time at Haniel to calmly analyse the situation and consider all options."
Haniel had repaid significant amounts of debts in recent months. As a result, the rating agencies Standard & Poor's and Moody's have raised their ratings for the family-owned Duisburg company (BB+ and Ba1 respectively).